A Saskatoon-based company is now listed on the Toronto Stock Exchange. ZYUS is a life sciences company focused finding new ways to treat chronic and neuropathic pain using cannabinoid formulations. Its website states that ZYUS is furthering the scientific understanding of cannabinoid by investigating the therapeutic potential to deliver a safer, more effective alternative to current pain management therapies.